U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H28FN5O4
Molecular Weight 553.5835
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLP-1R agonist 3

SMILES

OC(=O)C1=CC2=C(C=C1)N=C(CN3CCC(=CC3)C4=NC(OCC5=CC=C(C=C5F)C#N)=CC=C4)N2C[C@@H]6CCO6

InChI

InChIKey=HLOTYODPTNOHMJ-DEOSSOPVSA-N
InChI=1S/C31H28FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-8,14-15,24H,9-13,17-19H2,(H,38,39)/t24-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
GLP-1R agonist 3
Common Name English
1H-Benzimidazole-6-carboxylic acid, 2-[[6-[(4-cyano-2-fluorophenyl)methoxy]-3?,6?-dihydro[2,4?-bipyridin]-1?(2?H)-yl]methyl]-1-[(2S)-2-oxetanylmethyl]-
Preferred Name English
2-[[6-[(4-Cyano-2-fluorophenyl)methoxy]-3?,6?-dihydro[2,4?-bipyridin]-1?(2?H)-yl]methyl]-1-[(2S)-2-oxetanylmethyl]-1H-benzimidazole-6-carboxylic acid
Systematic Name English
Code System Code Type Description
CAS
2428640-18-8
Created by admin on Wed Apr 02 09:54:24 GMT 2025 , Edited by admin on Wed Apr 02 09:54:24 GMT 2025
PRIMARY
FDA UNII
PR5LN3I82O
Created by admin on Wed Apr 02 09:54:24 GMT 2025 , Edited by admin on Wed Apr 02 09:54:24 GMT 2025
PRIMARY
PUBCHEM
150440053
Created by admin on Wed Apr 02 09:54:24 GMT 2025 , Edited by admin on Wed Apr 02 09:54:24 GMT 2025
PRIMARY